This study was conducted with the objective to evaluate serum adiponectin, insulin resistance, cardiovascular risk, and their correlation (if any) in patients with clinical or overt hypothyroidism and to evaluate the effect of levothyroxine on these parameters. Here, ADIPOQ is linked to Insulin resistance.